The U.S Supreme Court has declined to hear a slew of legal challenges filed by pharmaceutical companies such as AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis, and Boehringer Ingelheim.
The Centers for Medicare & Medicaid Services has published a guidance that spells out a process for states to use to exempt Medicaid recipients from the controversial work requirements established last year under President Trump’s “One Big Beautiful Bill Act.”
